Publications by authors named "Doug Looker"

Claim this Profile
P
Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Joan P Blonder, Sarah C Mutka, Xicheng Sun, Jian Qiu, Lucia H Green, Doug Looker

BMC Pulm Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADH IB expression, but not ADH III, is decreased in human lung cancer.
Sarah C Mutka, Lucia H Green, Evie L Verderber, Jane P Richards, Doug L Looker

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
Dorothy B Colagiovanni, Daniel W Drolet, Emilie Langlois-Forget, Marie-Pier Piché, Doug Looker

Regul Toxicol Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical 28-day inhalation toxicity assessment of s-nitrosoglutathione in beagle dogs and Wistar rats.
Dorothy B Colagiovanni, Daxa Borkhataria, Doug Looker, Detlef Schuler, Corinna Bachmann

Int J Toxicol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis